프리마켓
로그인 회원가입
CCLD
CCLD
CareCloud Inc
7월 27일 4:00 PM ET (한국 7/28 05:00)
$2.23
+0.01 ▲ +0.45%

케어클라우드(CCLD) is a Healthcare sector company, analyzed across 14 metrics on this page including P/E, EPS, dividends, RSI, and MACD.

시황 · 실적발표 · 매수매도 신호, 가장 먼저 받아보세요 🔔 구독
시가총액
$95M
스몰캡
P/E
21.9
적정 수준
배당수익률
없음
52주 위치
10%
저점 +9% · 고점 -44%
애널리스트
매수
C+
Fundamental health
vs. Health Information Services
수익성 ⓘ
Top 13%
성장 ⓘ
Top 37%
밸류에이션 ⓘ
Top 77%
재무 안정 ⓘ
Top 59%
💰 Is this stock pricier than usual right now? ⓘ
Compared to this company's own recent 4년 (not other companies).
Very cheap
Cheap
Typical
Pricey
🔥 Very pricey
Simply put — what you pay today to own $1 of this company's yearly earnings is 13852원. Over the past 4년, it usually traded around 15원. Earnings have also shrunk, which lifts the multiple — one of the priciest stretches of the past 4년.
Pricy doesn't mean bad — it means expectations are already baked in.· based on 3.5 profitable years
Index ⓘ -P/E ⓘ 21.93EPS (ttm) ⓘ 0.1Insider Own ⓘ 15.59%Shs Outstand ⓘ 42.5MPerf Week ⓘ -1.76%
Market Cap ⓘ 0.09BForward P/E ⓘ 7.6EPS next Y ⓘ 56.44%Insider Trans ⓘ -Shs Float ⓘ 35.9MPerf Month ⓘ 7.21%
Enterprise Value ⓘ 0.10BPEG ⓘ -EPS next Q ⓘ 0.02Inst Own ⓘ 27.98%Short Float ⓘ 1.29%Perf Quarter ⓘ -26.89%
Income ⓘ 0.00BP/S ⓘ 0.76EPS this Y ⓘ 87.5%Inst Trans ⓘ 4.92%Short Ratio ⓘ 1.1Perf Half Y ⓘ -23.1%
Sales ⓘ 0.12BP/B ⓘ 1.62EPS next 5Y ⓘ -ROA ⓘ 12.19%Short Interest ⓘ 0.46MPerf YTD ⓘ -23.63%
Book/sh ⓘ 1.37P/C ⓘ 24.61EPS past 3/5Y ⓘ -ROE ⓘ 17.37%52W High ⓘ -44.39% ($4.01)Perf Year ⓘ -8.98%
Cash/sh ⓘ 0.09P/FCF ⓘ 4.21Sales past 3/5Y ⓘ -4.61% 2.77%ROIC ⓘ 15.77%52W Low ⓘ 9.31% ($2.04)Perf 3Y ⓘ -27.12%
Dividend Est. ⓘ -EV/EBITDA ⓘ 3.36EPS Y/Y TTM ⓘ 147.09%Gross Margin ⓘ 34.35%Volatility(W/M) ⓘ 3.11% 4.35%Perf 5Y ⓘ -71.95%
Dividend TTM ⓘ -EV/Sales ⓘ 0.78Sales Y/Y TTM ⓘ 10.34%Oper. Margin ⓘ 9.01%ATR (14) ⓘ 0.09Perf 10Y ⓘ 114.42%
Dividend Ex-Date ⓘ -Quick Ratio ⓘ 1.09EPS Q/Q ⓘ 71.27%Profit Margin ⓘ 3.47%RSI (14) ⓘ 47.4Recom ⓘ 1.67
Dividend Gr. 3/5Y ⓘ -Current Ratio ⓘ 1.11Sales Q/Q ⓘ 13.17%SMA20 ⓘ -0.63% ($2.24)Beta ⓘ 1.51Target Price ⓘ $6.12
Payout ⓘ -Debt/Eq ⓘ 0.1Earnings ⓘ 2026/8/6SMA50 ⓘ -1.21% ($2.26)Rel Volume ⓘ 0.37Prev Close ⓘ $2.22
Employees ⓘ 3650LT Debt/Eq ⓘ 0.06EPS/Sales Surpr. ⓘ -49.25% 2.5%SMA200 ⓘ -20.41% ($2.8)Avg Volume(3M) ⓘ 0.42MPrice ⓘ $2.23
IPO ⓘ 2014/7/23Option/Short ⓘ Yes/YesTrades ⓘ 1010Volume ⓘ 156,113Change ⓘ 0.45%
Quarterly earnings trend SEC filings · USD
24.6
24.9
24.12*
25.3
25.6
25.9
25.12*
26.3
Revenue Net income 최근 분기: 매출 $31M (YoY +13%) · 순이익 $1M (YoY -53%)
* Q4 figures are derived from the annual filing (10-K) · loss-making quarters are underlined in red

📊 CareCloud Inc (CCLD) Investment Analysis

What kind of company is CareCloud Inc?

케어클라우드(CCLD)
Healthcare · Health Information Services
Small-Cap — Low Volume, High Volatility

CareCloud is a healthcare IT solutions provider for U.S. medical practices, offering billing and collections automation, practice management, and electronic medical records. The company focuses on digitizing administrative workflows for hospitals and physician offices through a cloud-based platform to improve operational efficiency at the point of care. CareCloud targets the small and mid-sized medical practice market with a service-based model that combines technology with specialized personnel.

Learn more about CareCloud Inc →
Market Cap
$0.1B
Approx. KRW 0.1 trillion
⚖️ 0% of Samsung Electronics
Market Cap Rank4570
Employees3,650people
IPO2014/07/23
Current Price$2.23 ≈ 3,055원
NASD · USA

Key Events

⏰ Upcoming events
🔔 Earnings release D-9
8월 6일 (목) · 장 시작 전
예상 매출 - · EPS $0.06
🎯 Ex-dividend date
No scheduled dividends
📜 Recent events
🔔 Earnings release 2026년 5월 7일 (목) · 장 시작 전 EPS -49.3% 매출 +2.5%
🔔 Earnings release 2026년 3월 12일 (목) · 장 시작 전 EPS +0.0% 매출 +7.3%

Is it profitable?

Solid company — profitability & finances both healthy
Strong earnings and excellent financial health
Profitability — How efficiently it makes money
Operating Margin
Profit kept from selling products and services (higher is better)
9.0%
✓ 우수
My positionTop 25%
Low range Average High range
Health Information Services 초소형주 Median -45.4% · Top 11%
💡 일반적으로 10% 이상이면 양호, 20% 이상이면 우수
Net Margin
Share of revenue left after taxes and interest are paid
3.5%
✓ 우수
My positionTop 25%
Low range Average High range
Health Information Services 초소형주 Median -63.7% · Top 11%
💡 일반적으로 8% 이상이면 양호, 15% 이상이면 우수
Gross Margin
Profit after subtracting raw-material costs only (signals product competitiveness)
34.4%
✓ 평균
My positionMid-range
Low range Average High range
Health Information Services 초소형주 Median 40.6% · Bottom 44%
💡 제조업 30%, IT/소프트웨어 50% 이상이면 우수 (업종별 편차 큼)
ROE
Annual return earned on shareholders' equity (15%+ is strong)
17.4%
✓ 우수
My positionTop 5%
Low range Average High range
Healthcare 초소형주 Median -98.0% · Top tier
💡 일반적으로 15% 이상이면 우수 (단, 부채 레버리지 효과 주의)
ROA
Annual earnings relative to total company assets
12.2%
✓ 우수
My positionTop 5%
Low range Average High range
Healthcare 초소형주 Median -59.3% · Top tier
💡 일반적으로 5% 이상이면 양호, 10% 이상이면 우수
ROIC
Return generated per dollar invested in the business
15.8%
✓ 우수
My positionTop 5%
Low range Average High range
Healthcare 초소형주 Median -77.3% · Top tier
💡 자본비용(보통 8~10%)보다 높으면 가치 창출, 15% 이상이면 우수
Financial health — Debt & liquidity burden
Debt-to-Equity (D/E)
Debt relative to equity (lower is healthier)
0.10
✓ Healthy debt
My positionMid-range
Low range Average High range
Health Information Services Median 0.19
💡 일반적으로 1.0 이하면 건전, 1.5까지는 무난 (금융·유틸·REIT는 구조적으로 높음)
Current Ratio
Liquid assets available to cover liabilities due within a year
1.11
✓ 평균
My positionMid-range
Low range Average High range
Health Information Services Median 1.76
💡 1.5~3.0 적정, 1.0 미만이면 단기 유동성 주의
Quick Ratio
Liquid assets excluding inventory, available for immediate use
1.09
✓ 양호
My positionMid-range
Low range Average High range
Health Information Services Median 1.76
💡 1.0 이상이면 안전, 0.5 미만이면 주의
* Ratings reflect relative position vs. peer-group distribution (same sector & size) plus absolute guards (loss & risk thresholds).

What's the outlook?

Positive Outlook
Price targets, growth, and valuation are favorable
애널리스트 목표가
$6.12
현재가 대비 +174.4%
💡 12개월 이내 도달을 전망하는 애널리스트 컨센서스 평균
예상 PER (Forward)
7.60배
💡 내년 예상 EPS 기준. 현재 PER과 비교해 이익 성장 반영 정도 확인
내년 EPS 예상 성장률
+56.4%
💡 10% 이상이면 견조한 성장, 마이너스는 이익 감소 예상
⚠ 이 데이터는 애널리스트 추정치이며 실제 결과와 다를 수 있습니다. 투자 결정은 추가 검토와 함께 하세요.

Did earnings meet expectations?

Average Earnings Performance
Slight tendency to beat estimates
1
예상 상회
1
예상 부합
0
예상 하회
50%
상회 비율
+3.6%
평균 서프라이즈
2026.05.07
상회
실적 $0.05 · 예상 $0.05 +7.1%
2026.03.12
부합
실적 $0.11 · 예상 $0.11 +0.0%
💡 예상보다 높은 실적을 자주 내는 기업은 실적 신뢰도가 높다고 평가됩니다. 단, 애널리스트 기대치가 낮게 설정되었을 수도 있으니 절대 수치도 함께 봐야 합니다.

Is it growing?

Strong Growth
Above the industry average, both historically and going forward
🔮 How much will it grow? (analyst forecasts)
This Year's EPS Outlook
Projected EPS growth rate for this year
+87.5%
우수
My positionTop 25%
Low range Average High range
미분류 초소형주 Median 29.4% · Top 21%
Next Year's EPS Outlook
Projected EPS growth rate for next year (analyst consensus)
+56.4%
양호
My positionMid-range
Low range Average High range
미분류 초소형주 Median 40.2% · Top 42%
📊 How much has it grown? (actual results)
Past 5-Year Revenue
How much revenue grew over the past 5 years
+2.8%
평균
My positionMid-range
Low range Average High range
미분류 초소형주 Median 2.8% · Bottom 50%
⚡ Short-term momentum
QoQ Revenue
Revenue change from the previous quarter (short-term momentum)
+13.2%
양호
My positionMid-range
Low range Average High range
미분류 초소형주 Median -2.6% · Top 34%
* Forecast values are analyst consensus estimates. Ratings are determined by relative position vs. peer group of the same growth style and size.
New to investing terms? Look it up in the financial dictionary →

Has the stock risen over the long term?

Long-term weakness — -140%p below the market
CCLD -72.0% · S&P 500 +68.4%
Excess return vs. market (price-based, ex-dividends)
5-year basis
vs S&P 500
-140.3%p
Significantly behind the market
vs Health Care (XLV)
-96.5%p
Significantly behind the sector average
1-year basis
vs S&P 500
-25.0%p
behind the market
vs Health Care (XLV)
-28.7%p
behind the sector average
Rank among peers
5-year return Top 25% Based on 10 peers
1-year return Top 13% Based on 19 peers
Current position within 52-week range
Low (-9.3%p) High (-44.4%p)
Current price is 9.3% above the 52-week low and 44.4% below the 52-week high
Recent risk (last 120 trading days)
Max drawdown
-45.4%
Annualized volatility
67.3%

Technical Indicators

Bollinger Bands · MACD · RSI · Stochastics · Ichimoku 5-line · recent 136-day series

Price · Bollinger Bands · Ichimoku Cloud

  • close
  • BB Upper
  • BB Mid
  • BB Lower
  • Tenkan
  • Kijun
  • Cloud (SpanA/B)

Bollinger Bands are upper and lower channels showing the closing price range (20 days · 2σ). Touching the upper band = overheated; touching the lower band = oversold. Ichimoku Cloud shows trend direction and strength through colored areas. Prices above the cloud indicate an uptrend; prices below indicate a downtrend. About Bollinger Bands →

🔴
Current diagnosis · 2026-07-27
Downtrend zone

Current price $2.23 below the midline ($2.25). Normal downward flow. Below the Ichimoku cloud (bearish).

MACD (12 · 26 · 9) Expand ▼

An indicator that uses the difference between the short-term EMA (12) and long-term EMA (26) to identify trend reversals. When MACD rises above the Signal line, it is a buy signal (golden cross); when it falls below, it is a sell signal (death cross). About MACD →

🔴
Current diagnosis · 2026-07-27
Bearish momentum holding

MACD -0.017 < Signal -0.015 in negative zone + Hist negative (-0.002). Weakness in progress.

RSI(14) · Stochastics %K(14) Expand ▼

RSI measures short-term buying and selling pressure on a scale of 0–100. 30 or below = oversold (a rebound may be possible); 70 or above = overbought (a pullback may be possible). Stoch %K similarly measures short-term momentum strength. RSI · Learn more about Stochastics →

🔴
Current diagnosis · 2026-07-27
Bearish zone

RSI 47.4 (below the neutral level of 50). Selling pressure leads, indicating a weak trend. Stoch %K is also 47.5.

※ "Current diagnosis" is an automated interpretation based on standard thresholds and is for reference only. Make your own comprehensive judgment before trading.

Is it attractive at this price?

Cheaper than peers in its industry
Cheap on Vs. Earnings·Vs. Sales·Vs. Cash Flow, Pricey on Vs. Assets
💡 How to read this — Compare against peers in the same industry to see what the price is cheap or expensive relative to. Example: cheap vs. earnings = stock price is low relative to what the company earns; expensive vs. assets = stock price is high relative to assets on the balance sheet.
💵 Vs. Earnings Cheap
🏢 Vs. Assets Pricey
🧾 Vs. Sales Cheap
💧 Vs. Cash Flow Cheap
💵 Vs. Earnings
PER Price-to-Earnings Ratio
How expensive the price is vs. earnings — lower is cheaper
21.93x
✓ Very cheap
My positionTop 25%
Low range Average High range
Health Information Services median 45.78x · Top 13% — relatively cheap within the industry
💡 PER 15 이하 저평가, 25 이상이면 성장성 검증 필요 (적자 기업은 의미 없음)
💵 Vs. Earnings
Forward PER Forward Price-to-Earnings Ratio
PER using next year's estimated earnings — reflects growth
7.60x
✓ Very cheap
My positionTop 5%
Low range Average High range
Health Information Services median 18.57x · Top 1% — relatively cheap within the industry
💡 향후 12개월 예상 EPS 기준 PER. 현재 PER보다 낮으면 이익 성장 중
🏢 Vs. Assets
PBR Price-to-Book Ratio
Price vs. the company's asset value — below 1 trades cheaper than assets
1.62x
✓ Pricey
My positionMid-range
Low range Average High range
Health Information Services 초소형주 median 0.90x · Around the industry average
💡 PBR 1 미만이면 청산가치 이하 (금융·제조업에서 특히 의미, IT는 낮은 비중)
🧾 Vs. Sales
PSR Price-to-Sales Ratio
Market cap vs. revenue — lower is cheaper relative to sales
0.76x
✓ Cheap
My positionMid-range
Low range Average High range
Health Information Services 초소형주 median 0.79x · Around the industry average
💡 PSR 2 이하 저평가, 10 초과면 고평가 (고성장 기업일 때만 정당화)
💧 Vs. Cash Flow
EV/EBITDA Enterprise Value Multiple
Total enterprise value ÷ operating cash earnings — a benchmark for M&A
3.36x
✓ Very cheap
My positionTop 5%
Low range Average High range
Health Information Services median 12.71x · Top 1% — relatively cheap within the industry
💡 EV/EBITDA 10 이하 저평가, 20 이상이면 고평가 (M&A 밸류 기준)
💧 Vs. Cash Flow
P/FCF Price-to-Free-Cash-Flow Ratio
Price vs. actual cash generation — lower means more efficient
4.21x
✓ Very cheap
My positionTop 5%
Low range Average High range
Health Information Services median 15.66x · Top 1% — relatively cheap within the industry
💡 P/FCF 20 이하면 현금창출 대비 저평가 (실질 수익성 기준)
Analyst target price (reference)
$6.12 vs. current price +174.4%
* Valuation is the stock's relative position within the industry peer group (same sector and market-cap range). Even when valuation looks attractive, check the 'Profitability' and 'Growth' sections too.
As of: Recent snapshot · Peer group: Health Information Services

Who owns it?

Ownership flow is positive
Institutional net buying +4.9% · Short interest light 1.3%
📈 Recent trading flow (6 months)
🧑‍💼 Insiders (executives & directors)
0.0%
Insiders little change
🏦 Institutions (funds & investors)
+4.9%
Institutions net buying
💡 Net change over the past 6 months. Shows how much insiders and institutions increased or reduced their holdings, in %.
👥 Holdings composition
🏦 Institutions 28.0%
Moderate institutional participation
Healthcare 초소형주 Median 14.2%
🧑‍💼 Insiders 15.6%
Founder/management large holders (strong skin-in-the-game)
Healthcare 초소형주 Median 16.1%
👤 Retail investors (estimated) 56.4%
Everyone excluding institutions and insiders
Institutions Insiders Retail (est.)
📉 Short-selling metrics
Short ratio
1.3%
Low — limited short-side pressure
Healthcare 초소형주 Median 3.9%
Past 90 days Little change
Short interest days to cover
1.1 days
Days needed to close short positions using average trading volume
🧮 Share count
Total shares outstanding 42.5M주
Float (tradable shares) 35.9M주
* Insider/institutional flows are based on net changes over the past 6 months. Trend is cumulative over the past 90 days.

ETFs holding CCLD

ETFs with the highest weightings · 10 total shown
IWC
IWC
iShares Micro-Cap ETF
0.03%
$1.4B
BSVO
BSVO
EA Bridgeway Omni Small-Cap Value ETF
0.03%
$2.4B
AVUV
AVUV
Avantis U.S. Small Cap Value ETF
0.01%
$30.0B
DFAC
DFAC
Dimensional U.S. Core Equity 2 ETF
0.00%
$47.5B
DFAS
DFAS
Dimensional U.S. Small Cap ETF
0.00%
$15.2B
* Based on official quarterly filings. Latest disclosure; actual current weights may differ.

How much does it pay in dividends?

This company does not pay a dividend

It may be a growth-focused firm reinvesting profits into expansion. Consider this growth-stock profile when investing.

Compare Industry Peers

💡 vs. sector average ▲ Favorable / ▼ Unfavorable (Lower PER and PBR are better; higher ROE and dividend yield are better)
Sorted by market cap, largest first
StockMarket CapPERPBRROEDividend YieldChange
CCLD CCLD This Stock
$94.8M21.9 ▲1.6 ▲17.37% ▲- +0.5%
LLY
$1.13T43.1 ▼36.2 ▼107.64% ▲0.58% ▼+0.1%
JNJ
$640.9B30.8 ▼7.5 ▼25.74% ▲2.02% ▲+1.0%
ABBV
$453.9B126.7 ▼- 15221.82% ▲2.67% ▲-0.9%
UNH
$379.3B26.9 ▼3.9 ▼12.49% ▲2.16% ▲-0.7%
MRK
$323.0B36.8 ▼7.0 ▼18.97% ▲2.5% ▲-0.2%
Sector Avg-26.12.7-48.83%1.23%-
📊
See the market at a glance with a real-time dashboard Track premarket, regular, and after-hours quotes, screeners, and heatmaps on a single screen
→

Related News & Content

📖 Company overview
케어클라우드(CCLD) 뭐하는 회사일까? - 주가 전망·실적·시총·관련주·본사 총정리
케어클라우드(CCLD)는 미국 의료기관용 청구·진료관리 헬스케어 IT 기업입니다. 케어클라우드 주가와 실적, 매출 구조, 경쟁사와 관련주를 함께 정리해 소형 헬스케어 기술주 투자 판단에 필요한 핵심 정보를 제공합니다.
📚 Related Investment Guides
미국주식 세금 총정리 2026 — 초보자를 위한 계산법과 절세 전략
2026년 미국주식 세금 총정리. 양도소득세 22% 계산법, 배당세 15% 원천징수, 손익통산, 절세 전략까지. 실제 금액 시뮬레이션과 세금 계산기로 내 세금을 직접 확인해보세요.

FAQ

What kind of company is 케어클라우드(CCLD)?

케어클라우드(CCLD) belongs to the Healthcare sector and operates in the Health Information Services industry.

What is the market cap of CCLD?

The market cap of CCLD is approximately $95M, ranking 4,570 within its sector.

What is the P/E ratio of CCLD?

CCLD has a P/E ratio of approximately 21.9x, which can be used to assess its valuation relative to the Healthcare sector average.

What is the 52-week high and low for CCLD?

CCLD has recorded a 52-week high of $4.01 and a low of $2.04.

시황 · 실적발표 · 매수매도 신호, 가장 먼저 받아보세요 🔔 구독

면책조항: 본 콘텐츠는 참고 자료이며 투자 권유가 아닙니다. 모든 투자의 책임은 투자자 본인에게 있습니다.